Melanoma vaccine (two RNAs, BioNTech/Ribological)

N/A

Report date: 2026/05/12 09:10:04

Base Information

Drug NameMelanoma vaccine (two RNAs, BioNTech/Ribological)
Drug Alias NameRBL-001/RBL-002RB-0001MERITRBL-002/RBL-001
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaGermany
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiontech SeRibological
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiontech Rna Pharmaceuticals Gmbh
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A